Agency Forms Undergoing Paperwork Reduction Act Review, 39438-39439 [2017-17518]
Download as PDF
39438
Federal Register / Vol. 82, No. 159 / Friday, August 18, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS—Continued
Type of respondents
Number of
respondents
Form name
Annual End of Year Survey ..............................................
Final Survey ......................................................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–17519 Filed 8–17–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–17–17ABC]
Proposed Project
mstockstill on DSK30JT082PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) has submitted the
following information collection request
to the Office of Management and Budget
(OMB) for review and approval in
accordance with the Paperwork
Reduction Act of 1995. The notice for
the proposed information collection is
published to obtain comments from the
public and affected agencies.
Written comments and suggestions
from the public and affected agencies
concerning the proposed collection of
information are encouraged. Your
comments should address any of the
following: (a) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the functions of the agency, including
whether the information will have
practical utility; (b) Evaluate the
accuracy of the agencies estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected; (d) Minimize the burden of
the collection of information on those
who are to respond, including through
the use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
VerDate Sep<11>2014
17:47 Aug 17, 2017
responses; and (e) Assess information
collection costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Written
comments and/or suggestions regarding
the items contained in this notice
should be directed to the Attention:
CDC Desk Officer, Office of Management
and Budget, Washington, DC 20503 or
by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Jkt 241001
Zika Postpartum Emergency Response
Survey (ZPER), Puerto Rico, 2017—
New—National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In December 2015, the Puerto Rico
Department of Health (PRDH) reported
the first locally acquired (index) case of
Zika virus disease in the United States.
Since then, 38,733 cases have been
confirmed in Puerto Rico, including
3,076 among pregnant women. Because
the most common mosquito vector of
Zika virus, Aedes aegypti, is present
throughout Puerto Rico, Zika virus
transmission is ongoing. The island has
been designated at the highest level of
risk according to a 3-tiered Zika virus
infection risk scale developed by CDC’s
Emergency Operations Center.
While pregnant women do not differ
from the general population in terms of
susceptibility to Zika virus infection or
severity of disease, they are at risk for
adverse pregnancy and birth outcomes
associated with Zika virus infection
during pregnancy. After review of the
available evidence, CDC concluded that
Zika virus infection during pregnancy is
a cause of microcephaly and other brain
defects.
Given the adverse pregnancy and
birth outcomes associated with Zika
virus infection during pregnancy, it is
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
230
58
Number of
responses per
respondent
1
1
Average
burden per
response
(in hours)
15/60
15/60
more important than ever to understand
the Zika-related concerns of pregnant
women, interactions regarding Zika
between pregnant women and their
health care providers, sources of
information that pregnant women
consult regarding Zika virus, and use of
recommended precautions by pregnant
women to reduce the risk of exposure to
Zika virus. This information was
successfully collected for the first time
in a hospital-based survey of women
24–48 hours after delivery by the Puerto
Rico Department of Health in the fall of
2016 (Emergency OMB approval,
Control #0920–1127), and has been
critical for informing clinical guidance,
developing communication messages,
and providing resources for pregnant
women.
The currently proposed data
collection includes three components to
follow-up on the initial effort. The first
component is a telephone follow-back
survey among a subset of the original
participants. This component would be
the first population-based sample of
postpartum women who were pregnant
during the early period of the Zika
outbreak, and would provide
information on the accessibility and
utilization of postpartum and newborn
services, and continued adherence to
Zika prevention behaviors. The second
component would be to repeat the
hospital-based survey of pregnant
women to assess the effectiveness of
emergency response efforts and to
determine where there is a need for
further refinement of efforts and
outstanding resource gaps; as with the
first hospital-based survey, there would
be subsequent telephone follow-up
survey with a subset of the participants.
The third and final component is the
addition of a separate hospital-based
survey for fathers of the infants born to
surveyed mothers. This component
would assess father’s concerns about
Zika related birth defects and
contribution to prevention efforts.
There are no costs to respondents
other than their time to participate.
E:\FR\FM\18AUN1.SGM
18AUN1
39439
Federal Register / Vol. 82, No. 159 / Friday, August 18, 2017 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Avg. burden
per response
(in hours)
Total burden
(in hours)
Type of respondents
Form name
Women with recent births ..................
Maternal hospital-based questionnaire.
Father hospital-based questionnaire
Follow-up phone questionnaire .........
2,990
1
25/60
1,247
1,790
3,070
1
1
15/60
15/60
448
768
............................................................
......................
........................
........................
2,463
Fathers with recently born infants .....
Women with live births 2–10 months
prior.
Total ............................................
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–17518 Filed 8–17–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2017–0069]
Effective Methods for Implementing
Water Management Programs (WMPs)
To Reduce Growth of Transmission of
Legionella spp.
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Request for information.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) in the
Department of Health and Human
Services (HHS) announces the opening
of a docket to obtain information on
effective methods for achieving
implementation of water management
programs (WMPs) intended to reduce
Legionella growth and transmission in
buildings at increased risk. The
information will inform CDC efforts to
prevent Legionnaires disease in the
United States. Information gathered
should also inform CDC efforts to
prevent disease due to other
opportunistic waterborne pathogens
(e.g., Pseudomonas, Acinetobacter,
Burkholderia, Stenotrophomonas,
nontuberculous mycobacteria, various
species of fungi, and Naegleria).
DATES: Written comments must be
received on or before October 17, 2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0069 by any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
mstockstill on DSK30JT082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:47 Aug 17, 2017
Jkt 241001
• Mail: Laura Cooley, National Center
for Immunization and Respiratory
Diseases, Division of Bacterial Diseases,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS
C25, Atlanta, GA 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to https://regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT:
Laura Cooley, National Center for
Immunization and Respiratory Diseases,
Division of Bacterial Diseases, Centers
for Disease Control and Prevention,
1600 Clifton Road NE., MS C25, Atlanta,
GA 30329. Email:
travellegionella@cdc.gov. Phone: (404)
639–2215.
SUPPLEMENTARY INFORMATION:
Background: CDC assists state and
local health departments with
Legionnaires disease response and
prevention efforts by providing
technical assistance and developing
resources focused on preventing and
investigating cases and outbreaks of
Legionnaires disease (https://
www.cdc.gov/legionella/).
Legionnaires disease, a severe,
sometimes fatal pneumonia, can occur
in persons who inhale aerosolized
droplets of water contaminated with the
bacterium Legionella. The rate of
reported cases of Legionnaires disease
in the United States has increased more
than four-fold since 2000.1 Legionella
and other waterborne pathogens can
multiply in large, complex building
water systems where there are gaps in
water system maintenance; thus, the
most effective strategy for prevention of
Legionnaires disease is through control
1 Garrison LE, Kunz JM, Cooley LA, et al. Vital
signs: Deficiencies in environmental control
identified in outbreaks of Legionnaires disease—
North America, 2000–2014. MMWR Morb Mortal
Wkly Rep 2016; 65:576–84. https://doi.org/
10.15585/mmwr.mm6522e1.
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
of Legionella in building water systems.
Water management programs (WMPs)
identify hazardous conditions and take
steps to minimize the growth and
spread of Legionella and other
waterborne pathogens in building water
systems. Developing and maintaining a
water management program is a multistep process that requires continuous
review.
In 2015, ASHRAE (formerly known as
the American Society of Heating,
Refrigerating, and Air-Conditioning
Engineers) published a consensus
standard for the primary prevention of
Legionnaires disease,2 which calls for
the development and implementation of
WMPs in buildings with large or
complex water systems and in buildings
that house people who are particularly
susceptible to Legionnaires disease.
ASHRAE recommends WMPs for the
following buildings and devices:
• Healthcare facilities where patients
stay overnight
• Buildings that house or treat people
who have chronic and acute medical
problems or weakened immune
systems
• Buildings that primarily house people
older than 65 years (like a retirement
home or assisted living facility)
• Buildings that have a centralized hot
water system (like a hotel or high-rise
apartment complex)
• Buildings 10 stories or more
(including basement levels)
• Devices that have been linked to
transmission of Legionella:
Æ Cooling towers
Æ Hot tubs (or spas) that are not
drained between each use
Æ Decorative fountains
Æ Centrally-installed misters,
atomizers, air washers, or
humidifiers
Additionally, stakeholders can use
CDC’s toolkit, Developing a Water
Management Program to Reduce
Legionella Growth & Spread in
Buildings: A Practical Guide to
2 ASHRAE 188: Legionellosis: Risk Management
for Building Water Systems June 26, 2015.
ASHRAE: Atlanta. www.ashrae.org.
E:\FR\FM\18AUN1.SGM
18AUN1
Agencies
[Federal Register Volume 82, Number 159 (Friday, August 18, 2017)]
[Notices]
[Pages 39438-39439]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17518]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-17-17ABC]
Agency Forms Undergoing Paperwork Reduction Act Review
The Centers for Disease Control and Prevention (CDC) has submitted
the following information collection request to the Office of
Management and Budget (OMB) for review and approval in accordance with
the Paperwork Reduction Act of 1995. The notice for the proposed
information collection is published to obtain comments from the public
and affected agencies.
Written comments and suggestions from the public and affected
agencies concerning the proposed collection of information are
encouraged. Your comments should address any of the following: (a)
Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility; (b) Evaluate the
accuracy of the agencies estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (c) Enhance the quality, utility, and clarity of
the information to be collected; (d) Minimize the burden of the
collection of information on those who are to respond, including
through the use of appropriate automated, electronic, mechanical, or
other technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to omb@cdc.gov. Written comments and/or
suggestions regarding the items contained in this notice should be
directed to the Attention: CDC Desk Officer, Office of Management and
Budget, Washington, DC 20503 or by fax to (202) 395-5806. Written
comments should be received within 30 days of this notice.
Proposed Project
Zika Postpartum Emergency Response Survey (ZPER), Puerto Rico,
2017--New--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
In December 2015, the Puerto Rico Department of Health (PRDH)
reported the first locally acquired (index) case of Zika virus disease
in the United States. Since then, 38,733 cases have been confirmed in
Puerto Rico, including 3,076 among pregnant women. Because the most
common mosquito vector of Zika virus, Aedes aegypti, is present
throughout Puerto Rico, Zika virus transmission is ongoing. The island
has been designated at the highest level of risk according to a 3-
tiered Zika virus infection risk scale developed by CDC's Emergency
Operations Center.
While pregnant women do not differ from the general population in
terms of susceptibility to Zika virus infection or severity of disease,
they are at risk for adverse pregnancy and birth outcomes associated
with Zika virus infection during pregnancy. After review of the
available evidence, CDC concluded that Zika virus infection during
pregnancy is a cause of microcephaly and other brain defects.
Given the adverse pregnancy and birth outcomes associated with Zika
virus infection during pregnancy, it is more important than ever to
understand the Zika-related concerns of pregnant women, interactions
regarding Zika between pregnant women and their health care providers,
sources of information that pregnant women consult regarding Zika
virus, and use of recommended precautions by pregnant women to reduce
the risk of exposure to Zika virus. This information was successfully
collected for the first time in a hospital-based survey of women 24-48
hours after delivery by the Puerto Rico Department of Health in the
fall of 2016 (Emergency OMB approval, Control #0920-1127), and has been
critical for informing clinical guidance, developing communication
messages, and providing resources for pregnant women.
The currently proposed data collection includes three components to
follow-up on the initial effort. The first component is a telephone
follow-back survey among a subset of the original participants. This
component would be the first population-based sample of postpartum
women who were pregnant during the early period of the Zika outbreak,
and would provide information on the accessibility and utilization of
postpartum and newborn services, and continued adherence to Zika
prevention behaviors. The second component would be to repeat the
hospital-based survey of pregnant women to assess the effectiveness of
emergency response efforts and to determine where there is a need for
further refinement of efforts and outstanding resource gaps; as with
the first hospital-based survey, there would be subsequent telephone
follow-up survey with a subset of the participants. The third and final
component is the addition of a separate hospital-based survey for
fathers of the infants born to surveyed mothers. This component would
assess father's concerns about Zika related birth defects and
contribution to prevention efforts.
There are no costs to respondents other than their time to
participate.
[[Page 39439]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Women with recent births....... Maternal hospital- 2,990 1 25/60 1,247
based
questionnaire.
Fathers with recently born Father hospital- 1,790 1 15/60 448
infants. based
questionnaire.
Women with live births 2-10 Follow-up phone 3,070 1 15/60 768
months prior. questionnaire.
-------------------------------------------------------------
Total...................... ................. ............ .............. .............. 2,463
----------------------------------------------------------------------------------------------------------------
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-17518 Filed 8-17-17; 8:45 am]
BILLING CODE 4163-18-P